Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment

Strahlentherapie und Onkologie

Volumn 188, Issue 1, 2012, Pages 29-34

  Manapov, F ^a,b   Klocking S ^b   Niyazi, M ^a   Belka, C ^a   Hildebrandt, G ^b   Fietkau, R ^b,c   Klautke, G ^b,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cancer; Chemoradiotherapy; Duration; Multimodal treatment; Small cell lung carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; IRINOTECAN;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PERFORMANCE; PROGRESSION FREE SURVIVAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SKULL IRRADIATION; SURVIVAL RATE; THORACIC RADIATION THERAPY; TREATMENT DURATION;

ACTUARIAL ANALYSIS; AGED; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE;

EID: 84856355238     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0016-9     Document Type: Article

References (34)

1. Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med 12:476-484 (Pubitemid 29372887)
2. Chen J, Jiang R, Garces Y et al (2010) Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer 67:221-226
3. De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J et al (2006) Systematic review and meta-analysis of randomized, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 17:543-552
4. De Ruysscher D, Pijls-Johannesma M, Bentzen SM et al (2006) Time between the first day of chemotherapy and last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 24:1057-1063 (Pubitemid 46638802)
5. Fietkau R, Sauer R (2002) Die frühzeitige Radiotherapie im Rahmen der radiochemotherapie des kleinzelligen Bronchialkarzinoms ist im Stadium "Limited Disease" der späten Bestrahlung überlegen. Strahlenther Onkol 178:585-588 (Pubitemid 35387832)
6. Fried DB, Morris DE, Poole C et al (2004) Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 22:4837-4845
7. Früh M, Kacsir B, Ess S et al (2011) Extrapulmonary small cell carcinoma: an indication for prophylactic cranial irradiation? A single center experience. Strahlenther Onkol 187:561-567
8. Gregor A, Drings P, Rinaldi M et al (1995) Acute toxicity of alternating schedule of chemotherapy and irradiation in limited small-cell lung cancer in a pilot study (08877) of the EORTC Lung Cancer Cooperative Group. Ann Oncol 6:403-405 (letter
9. Gregor A, Drings P, Burghouts J et al (1997) Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organisation for Research and Treatment of Cancer Lung Cancer Cooperative Group study. J Clin Oncol 15:2840-2847
10. Ichinose Y, Hara N, Ohta M et al (1989) Brain metastases in patients with limited small cell lung cancer achieving complete remission. Correlation with TNM Staging. Chest 96:1332-1335 (Pubitemid 20000831)
11. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1997) Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small cell lung cancer. J Clin Oncol 15:893-900 (Pubitemid 27106269)
12. Klautke G, Sauer R, Fietkau R (2008) Combined treatment modality in small cell lung cancer. The impact of radiotherapy on survival. Strahlenther Onkol 184:61-66
13. Klautke G, Fahndrich S, Semrau S et al (2006) Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I study. Lung Cancer 53:183-188 (Pubitemid 43994232)
14. Manapov F, Klautke G, Fietkau R (2008) Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thorac Oncol 3:652-655 (Pubitemid 351787312)
15. Manapov F (2009) Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy. J Neurooncol 98:349-355
16. Matsumoto Y, Mari S, Makoto S et al (2003) Chemoradiotherapy for limited disease small cell lung cancer. Niigata Kenritsu Byoin Iggakkaishi 51:6-13
17. Miller KL, Marks LB, Sibley GS et al (2003) Routine use of approximately 60 Gy once- daily thoracic irradiation for patients with limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 56:355-359 (Pubitemid 36542893)
18. Movsas B, Moughan J, Komaki R et al (2003) Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 21:4553-4559 (Pubitemid 46594026)
19. Murray N, Coy P, Pater JL et al (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited stage small-cell lung cancer. J Clin Oncol 11:336-344 (Pubitemid 23046826)
20. Pignon JP, Ariagada R, Ihde DC et al (1992) A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 327:1618-1624
21. Pijls -Johannesma MCG, De Ruysscher D, Lambin P et al (2004) Early versus late chest radiotherapy for limited stage small-cell lung cancer. Cochrane Database Syst Rev:CD004700
22. Rades D, Nadrowitz R, Buchmann I et al (2010) Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC). Strahlenther Onkol 186:458-462
23. Roeder F, Friedrich J, Timke C et al (2010) Correlation of patient-related factors and dose-volume histogramm parameters with the onset of radiation pneumonitis in patients with small cell lung cancer. Strahlenther Onkol 186:149-156
24. Sas-Korczyska B, Korzeniowski S, Wójcik E (2010) Comparison of the effectiveness of late and early prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. Strahlenther Onkol 186:315-319
25. Schnabel T, Schmitt G (1993) The role of radiotherapy in the management of small cell lung cancer (SCLC). Strahlenther Onkol 169:329-338 (Pubitemid 23219598)
26. Seute T, Leffers P, Wilmink JT et al (2006) Response of asymptomatic brain metastases from small-cell lung cancer to systemic first -line chemotherapy. J Clin Oncol 24:2079-2083 (Pubitemid 46622118)
27. Skarlos DV, Samantas E, Briassoulis E et al (2001) Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 12:1231-1238 (Pubitemid 32994750)
28. Spiro SG, James LE, Rudd RM et al (2006) Early compared with late radiotherapy in combined modality treatment for limited disease cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 24:3823-3829
29. Takada M, Fukuoka M, Kawahara M et al (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054-3060 (Pubitemid 34791094)
30. Tomita N, Kodaira T, Hida T et al (2010) The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 76:1121-1126
31. Turrisi AT 3rd, Kim K, Blum R et al (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265-271 (Pubitemid 29063268)
32. Videtic GM, Truong PT, Ash RB et al (2005) Does sex influence the impact that smoking, treatment interruption and impaired pulmonary function have on outcomes in limited stage small cell lung cancer treatment? Can Respir J 12:245-250 (Pubitemid 41387421)
33. Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890-895
34. Work E, Nielsen OS, Bentzen SM et al (1997) Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. J Clin Oncol 15:3030-3037 (Pubitemid 27377494)